Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Fructose-Induced Intestinal Microbiota Shift Following Two Types of Short-Term High-Fructose Dietary Phases.

Tytuł:
Fructose-Induced Intestinal Microbiota Shift Following Two Types of Short-Term High-Fructose Dietary Phases.
Autorzy:
Beisner J; Institute of Nutritional Medicine, University of Hohenheim, Fruwirthstr. 12, 70599 Stuttgart, Germany.
Gonzalez-Granda A; Institute of Nutritional Medicine, University of Hohenheim, Fruwirthstr. 12, 70599 Stuttgart, Germany.
Basrai M; Institute of Nutritional Medicine, University of Hohenheim, Fruwirthstr. 12, 70599 Stuttgart, Germany.
Damms-Machado A; Institute of Nutritional Medicine, University of Hohenheim, Fruwirthstr. 12, 70599 Stuttgart, Germany.
Bischoff SC; Institute of Nutritional Medicine, University of Hohenheim, Fruwirthstr. 12, 70599 Stuttgart, Germany.
Źródło:
Nutrients [Nutrients] 2020 Nov 10; Vol. 12 (11). Date of Electronic Publication: 2020 Nov 10.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI Publishing
MeSH Terms:
Dietary Supplements*
Feces/*microbiology
Fructose/*administration & dosage
Gastrointestinal Microbiome/*physiology
RNA, Ribosomal, 16S/*genetics
Adult ; Animals ; Bacteroidetes/growth & development ; Diet, Carbohydrate-Restricted ; Female ; Firmicutes/growth & development ; Fruit ; Healthy Volunteers ; High Fructose Corn Syrup/administration & dosage ; Humans ; Pilot Projects ; Young Adult
References:
Nutrients. 2018 Jun 13;10(6):. (PMID: 29899272)
PLoS One. 2016 Jul 19;11(7):e0159223. (PMID: 27434092)
Pharmacol Res. 2013 Mar;69(1):52-60. (PMID: 23147033)
Syst Appl Microbiol. 2002 Apr;25(1):46-51. (PMID: 12086188)
Science. 2011 Oct 7;334(6052):105-8. (PMID: 21885731)
Anaerobe. 2012 Oct;18(5):523-9. (PMID: 22982042)
Front Microbiol. 2016 Feb 17;7:185. (PMID: 26925050)
Mol Nutr Food Res. 2018 Apr 30;:e1800066. (PMID: 29710384)
Am J Gastroenterol. 2007 Dec;102(12):2716-7. (PMID: 18042105)
Cell Metab. 2018 Feb 6;27(2):351-361.e3. (PMID: 29414685)
Nucleic Acids Res. 2013 Jan 7;41(1):e1. (PMID: 22933715)
Gastroenterology. 2016 Oct;151(4):733-746.e12. (PMID: 27342212)
AJR Am J Roentgenol. 2009 Apr;192(4):909-14. (PMID: 19304694)
J Hepatol. 2008 Jun;48(6):993-9. (PMID: 18395287)
Adv Immunol. 2014;121:91-119. (PMID: 24388214)
Diabetes. 2008 Jun;57(6):1470-81. (PMID: 18305141)
Curr Hypertens Rep. 2010 Apr;12(2):105-12. (PMID: 20424937)
J Hepatol. 2018 May;68(5):1063-1075. (PMID: 29408694)
Gut. 2016 Mar;65(3):426-36. (PMID: 26100928)
Am J Clin Nutr. 2013 Aug;98(2):349-57. (PMID: 23783298)
Adv Nutr. 2013 Mar 01;4(2):246-56. (PMID: 23493541)
Liver Int. 2008 Aug;28(7):1026-33. (PMID: 18397235)
Nature. 2020 Mar;579(7800):586-591. (PMID: 32214246)
J Nutr. 2017 May;147(5):770-780. (PMID: 28356436)
Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):334-40. (PMID: 21587065)
J Agric Food Chem. 2019 Jul 10;67(27):7726-7737. (PMID: 31203627)
Nutrients. 2019 Dec 29;12(1):. (PMID: 31905727)
Nutrients. 2018 Jul 27;10(8):. (PMID: 30060512)
Immune Netw. 2014 Dec;14(6):277-88. (PMID: 25550694)
PLoS One. 2016 Jan 05;11(1):e0146177. (PMID: 26731543)
Mol Nutr Food Res. 2017 Aug;61(8):. (PMID: 28463404)
Nature. 2006 Dec 21;444(7122):1022-3. (PMID: 17183309)
PLoS One. 2015 Aug 05;10(8):e0134893. (PMID: 26244577)
Nature. 2014 Jan 23;505(7484):559-63. (PMID: 24336217)
Nutrients. 2018 Sep 06;10(9):. (PMID: 30200659)
Cell Metab. 2018 Mar 6;27(3):559-571.e5. (PMID: 29456073)
Front Genet. 2018 Jun 19;9:203. (PMID: 29971089)
Obesity (Silver Spring). 2010 Jan;18(1):190-5. (PMID: 19498350)
Eur J Nutr. 2013 Mar;52(2):537-45. (PMID: 22543624)
Br J Nutr. 2014 Jul 14;112(1):1-7. (PMID: 24708895)
J Nutr. 2008 Aug;138(8):1452-5. (PMID: 18641190)
mSystems. 2017 Nov 14;2(6):. (PMID: 29152585)
Food Nutr Res. 2017 Jun 9;61(1):1331657. (PMID: 28659742)
Front Physiol. 2018 Apr 26;9:411. (PMID: 29755364)
Am J Clin Nutr. 2015 Jun;101(6):1144-54. (PMID: 25904601)
PLoS One. 2010 Nov 29;5(11):e15046. (PMID: 21151493)
Int J Syst Evol Microbiol. 2002 Nov;52(Pt 6):2141-2146. (PMID: 12508881)
J Nutr. 2015 Oct;145(10):2265-72. (PMID: 26338891)
Eur J Nutr. 2013 Mar;52(2):527-35. (PMID: 22543623)
J Nutr Biochem. 2018 May;55:185-199. (PMID: 29539590)
FEMS Microbiol Rev. 2014 Sep;38(5):996-1047. (PMID: 24861948)
Am J Clin Nutr. 2004 Apr;79(4):537-43. (PMID: 15051594)
Cell Rep. 2019 Jan 2;26(1):222-235.e5. (PMID: 30605678)
Physiol Behav. 2017 May 1;173:305-317. (PMID: 28249783)
Appl Biochem Biotechnol. 2014 Apr;172(8):3810-26. (PMID: 24574250)
PLoS One. 2011;6(9):e25200. (PMID: 21966454)
Int J Obes (Lond). 2008 Nov;32(11):1720-4. (PMID: 18779823)
Gut. 2013 Dec;62(12):1787-94. (PMID: 23197411)
J Biosci. 2012 Sep;37(4):647-57. (PMID: 22922190)
PLoS One. 2017 Aug 23;12(8):e0182977. (PMID: 28832650)
BMC Gastroenterol. 2006 Nov 02;6:33. (PMID: 17081293)
Infect Immun. 1983 Jul;41(1):423-5. (PMID: 6408004)
Int J Mol Med. 2019 Mar;43(3):1487-1496. (PMID: 30628636)
Bioinformatics. 2011 Mar 15;27(6):863-4. (PMID: 21278185)
Hepatology. 2013 Feb;57(2):601-9. (PMID: 23055155)
Environ Microbiol. 2010 Feb;12(2):304-14. (PMID: 19807780)
Methods Enzymol. 2013;531:465-85. (PMID: 24060133)
ISME J. 2014 Nov;8(11):2218-30. (PMID: 24763370)
Nutrition. 2020 Jul - Aug;75-76:110766. (PMID: 32305658)
J Clin Invest. 2009 May;119(5):1322-34. (PMID: 19381015)
Front Immunol. 2017 Sep 19;8:1159. (PMID: 28970836)
Appl Environ Microbiol. 2000 Apr;66(4):1654-61. (PMID: 10742256)
Br J Nutr. 2018 Nov;120(9):1014-1022. (PMID: 30355393)
PLoS One. 2016 Feb 26;11(2):e0149564. (PMID: 26919743)
Am J Clin Nutr. 2011 Aug;94(2):479-85. (PMID: 21677052)
Nutrients. 2018 May 08;10(5):. (PMID: 29738477)
Grant Information:
FKZ: 01GI0843 Bundesministerium für Bildung und Forschung
Contributed Indexing:
Keywords: NAFLD; fructose; host-microbe interactions; metabolic syndrome; microbiota; obesity
Substance Nomenclature:
0 (High Fructose Corn Syrup)
0 (RNA, Ribosomal, 16S)
30237-26-4 (Fructose)
Entry Date(s):
Date Created: 20201113 Date Completed: 20210412 Latest Revision: 20210412
Update Code:
20240105
PubMed Central ID:
PMC7697676
DOI:
10.3390/nu12113444
PMID:
33182700
Czasopismo naukowe
High consumption of fructose and high-fructose corn syrup is related to the development of obesity-associated metabolic diseases, which have become the most relevant diet-induced diseases. However, the influences of a high-fructose diet on gut microbiota are still largely unknown. We therefore examined the effect of short-term high-fructose consumption on the human intestinal microbiota. Twelve healthy adult women were enrolled in a pilot intervention study. All study participants consecutively followed four different diets, first a low fructose diet (< 10 g/day fructose), then a fruit-rich diet (100 g/day fructose) followed by a low fructose diet (10 g/day fructose) and at last a high-fructose syrup (HFS) supplemented diet (100 g/day fructose). Fecal microbiota was analyzed by 16S rRNA sequencing. A high-fructose fruit diet significantly shifted the human gut microbiota by increasing the abundance of the phylum Firmicutes , in which beneficial butyrate producing bacteria such as Faecalibacterium , Anareostipes and Erysipelatoclostridium were elevated, and decreasing the abundance of the phylum Bacteroidetes including the genus Parabacteroides . An HFS diet induced substantial differences in microbiota composition compared to the fruit-rich diet leading to a lower Firmicutes and a higher Bacteroidetes abundance as well as reduced abundance of the genus Ruminococcus . Compared to a low-fructose diet we observed a decrease of Faecalibacterium and Erysipelatoclostridium after the HFS diet. Abundance of Bacteroidetes positively correlated with plasma cholesterol and LDL level, whereas abundance of Firmicutes was negatively correlated. Different formulations of high-fructose diets induce distinct alterations in gut microbiota composition. High-fructose intake by HFS causes a reduction of beneficial butyrate producing bacteria and a gut microbiota profile that may affect unfavorably host lipid metabolism whereas high consumption of fructose from fruit seems to modulate the composition of the gut microbiota in a beneficial way supporting digestive health and counteracting harmful effects of excessive fructose.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies